Work

Evaluation of the response assessment criteria in newly diagnosed and recurrent glioblastoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.2020

Authors: Gilbert Youssef, Rifaquat Rahman, Mary Jane Lim-Fat, Camden Bay, Wenya Linda L. Bi, Daniel Cagney, YuhShin Chang, Matthew Nicholas Desalvo, Thomas Flood, Elizabeth R. Gerstner, Luis Nicolas Gonzalez Castro, Jeffrey Guenette, Albert Eusik Kim, Eudocia Quant Lee, J. Ricardo Ricardo McFaline Figueroa, Christopher Potter, David A. Reardon, Benjamin M. Ellingson, Raymond Yi-kun Huang, Patrick Y. Wen

Institutions: Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Mater Misericordiae University Hospital, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center, University of California, Los Angeles

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281782966

Cites:

Cited by:

Related to: 10